Government of Cambodia   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Phnom Penh Cambodia (1993)

Organization Overview

First Clinical Trial
2004
NCT00078182
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ministry of National Defense, Royal Cambodian Armed Forces Department of Health | Ministry of Planning, Cambodia | National Ethics Committee for Health Research(NECHR) | National Institute of Public Health, Cambodia | NCHADS - Ministry of Health of Cambodia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Communicable Diseases (Phase 3)

Hemoglobinopathies (Phase 1)

HIV Infections (Phase 3)

Infections (Phase 3)

Inflammation (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Parasitic Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 19